Citadel Advisors - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$57,142,532
+9.8%
2,788,801
+6.5%
0.01%
+9.1%
Q2 2023$52,037,702
+13.1%
2,618,908
-2.5%
0.01%
+10.0%
Q1 2023$45,994,889
-11.3%
2,685,049
+1.3%
0.01%
-16.7%
Q4 2022$51,865,980
+78.5%
2,650,280
+45.6%
0.01%
+100.0%
Q3 2022$29,055,000
+38.3%
1,820,521
+19.3%
0.01%
+20.0%
Q2 2022$21,007,000
-25.8%
1,526,639
-14.5%
0.01%
-16.7%
Q1 2022$28,330,000
-23.3%
1,786,255
+5.5%
0.01%
-25.0%
Q4 2021$36,957,000
-6.2%
1,692,966
+28.4%
0.01%0.0%
Q3 2021$39,406,000
-0.5%
1,318,376
+47.4%
0.01%
-11.1%
Q2 2021$39,609,000
+14.2%
894,279
+14.4%
0.01%
+12.5%
Q1 2021$34,671,000
-55.3%
781,398
-44.8%
0.01%
-60.0%
Q4 2020$77,561,000
+205.2%
1,414,303
+27.2%
0.02%
+185.7%
Q3 2020$25,416,000
+12.0%
1,111,809
+2.6%
0.01%
-12.5%
Q2 2020$22,689,000
+47.6%
1,084,004
-1.6%
0.01%
+14.3%
Q1 2020$15,373,000
-46.2%
1,102,069
-12.2%
0.01%
-41.7%
Q4 2019$28,566,000
+103.4%
1,255,058
+4.1%
0.01%
+71.4%
Q3 2019$14,043,000
-16.8%
1,205,401
+7.1%
0.01%
-12.5%
Q2 2019$16,883,000
-14.1%
1,125,468
+0.4%
0.01%
-20.0%
Q1 2019$19,655,000
+20.1%
1,120,574
+1.4%
0.01%
+11.1%
Q4 2018$16,372,000
-13.8%
1,104,757
+43.3%
0.01%
+12.5%
Q3 2018$18,986,000
+16.7%
771,146
-7.0%
0.01%0.0%
Q2 2018$16,275,000
+106.9%
829,066
+97.6%
0.01%
+100.0%
Q1 2018$7,866,000419,5020.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders